Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-17
FGENFibrogen IncKurkijarvi KaleviDirS - Sale$46.65-2,00024,000-8%-$93,300
2017-11-16
LOXOLoxo Oncology, Inc.Bonita David PDirS - Sale$74.26-270,0001,458,000-16%-$20,051,389
2017-11-16
LOXOLoxo Oncology, Inc.Orbimed Advisors LLCDirS - Sale$74.26-270,0001,458,000-16%-$20,051,389
DM
2017-11-16
PCRXPacira Pharmaceuticals, Inc.Williams Kristen MarieCAO, GCS - Sale+OE$40.00-10,00021,312-32%-$400,021
2017-11-20
PCRXPacira Pharmaceuticals, Inc.Jones James BSVP, Chief Medical OfficerS - Sale$41.11-85016,823-5%-$34,942
2017-11-16
VRXValeant Pharmaceuticals International, Inc.Paulson JohnDirP - Purchase$14.40+344,21620,839,035+2%+$4,955,506
2017-11-16
VRXValeant Pharmaceuticals International, Inc.Paulson JohnDirS - Sale$14.39-344,21620,839,035-2%-$4,952,821
D
2017-11-17
ABTAbbott LaboratoriesBlaser Brian JEVPS - Sale+OE$55.55-23,866128,854-16%-$1,325,720
M
2017-11-16
BGNEBeigene, Ltd.Huang JaneCMO, HematologyS - Sale$86.25-1,600266,000-1%-$138,000
2017-11-17
LGNDLigand Pharmaceuticals IncAryeh JasonDirS - Sale$140.22-24,400154,901-14%-$3,421,368
2017-11-17
LGNDLigand Pharmaceuticals IncHiggins John LCEOS - Sale$140.34-2,258141,284-2%-$316,888
D
2017-11-16
MRTXMirati Therapeutics, Inc.Boxer Capital, LLC10%P - Purchase$13.00+400,0003,135,966+15%+$5,200,000
2017-11-16
MRTXMirati Therapeutics, Inc.Broadfin Healthcare Master Fund Ltd10%S - Sale$18.05-60,0002,728,601-2%-$1,083,000
D
2017-11-16
PRGOPerrigo Co PlcFarrington ThomasEVP, CIOS - Sale+OE$87.25-2135,070-4%-$18,585
2017-11-16
OCULOcular Therapeutix, IncSawhney AmarpreetExec. COB, 10%P - Purchase$5.18+19,0002,655,332+1%+$98,420
2017-11-15
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasCOB, Pres, CEOS - Sale$15.53-50,000558,987-8%-$776,500
M
2017-11-15
LXRXLexicon Pharmaceuticals, Inc.Invus Public Equities, L.P.Dir, 10%P - Purchase$10.11+180,72758,274,6500%+$1,826,896
D
2017-11-16
AMPHAmphastar Pharmaceuticals, Inc.Shohet Stephen B.DirS - Sale+OE$18.04-7,86224,116-25%-$141,862
2017-11-15
AMPHAmphastar Pharmaceuticals, Inc.Gerst Diane G.EVP, QA, Regulatory AffairsS - Sale$17.77-52332,256-2%-$9,292
D
2017-11-17
LGNDLigand Pharmaceuticals IncLamattina John LDirS - Sale+OE$139.79-4,00020,956-16%-$559,160
D
2017-11-15
FGENFibrogen IncKearns Thomas F JrDirS - Sale+OE$45.22-18,000248,564-7%-$813,960
M
2017-11-16
FGENFibrogen IncNeff Thomas BCEOS - Sale$46.63-38,6363,285,887-1%-$1,801,638
D
2017-11-16
MRTXMirati Therapeutics, Inc.Christensen JamieSVP, Chief Science OfficerS - Sale+OE$18.00-10,2752,395-81%-$184,950
2017-11-17
ADROAduro Biotech, Inc.Templeman BlaineEVP, GCS - Sale$8.85-24358,8340%-$2,151
D
2017-11-15
ADROAduro Biotech, Inc.Lew JenniferSVP of FinanceS - Sale+OE$8.95-6,60062,338-10%-$59,070
D
2017-11-15
IONSIonis Pharmaceuticals IncKlein Joseph IIIDirS - Sale+OE$53.56-2,25010,039-18%-$120,510
ADM
2017-11-13
EBSEmergent Biosolutions Inc.El-Hibri FuadCOB, 10%S - Sale+OE$40.37-40,0007,398,621-1%-$1,614,800
D
2017-11-15
ALNYAlnylam Pharmaceuticals, Inc.Maraganore JohnCEOS - Sale+OE$126.86-74,000152,670-33%-$9,387,951
D
2017-11-15
PCRXPacira Pharmaceuticals, Inc.Stack David MCEO, COBS - Sale+OE$38.34-58,885120,083-33%-$2,257,708
2017-11-16
LGNDLigand Pharmaceuticals IncKozarich John WDirS - Sale$141.71-5,00035,649-12%-$708,550
2017-11-17
LGNDLigand Pharmaceuticals IncKorenberg Matthew EVP, Finance, CFOS - Sale$142.63-6,5598,147-45%-$935,510
2017-11-16
LGNDLigand Pharmaceuticals IncHiggins John LCEOS - Sale$142.53-5,269143,542-4%-$750,991
D
2017-11-16
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$121.12-7,061681,770-1%-$855,204
2017-11-15
BDSIBiodelivery Sciences International IncSears Samuel P JrDirS - Sale$2.25-12,00082,863-13%-$27,000
2017-11-15
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$149.12-306106,0110%-$45,630
2017-11-15
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, Corp ControllerS - Sale$147.29-2316,8030%-$3,388
2017-11-15
VRTXVertex Pharmaceuticals Inc / MaSmith Ian FEVP, COOS - Sale$147.29-746,1940%-$1,031
2017-11-15
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, CROS - Sale$147.29-8351,5920%-$12,225
2017-11-15
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$147.29-22142,092-1%-$32,551
M
2017-11-15
DMPIDelmar Pharmaceuticals, Inc.Bell John KDirP - Purchase$0.81+20,00095,019+27%+$16,200
2017-11-15
BPMCBlueprint Medicines CorpLynch DanielDirS - Sale$63.38-5,000204,342-2%-$316,898
M
2017-11-16
CORICorium International, Inc.Broadfin Healthcare Master Fund Ltd10%S - Sale$10.96-500,0003,568,626-12%-$5,479,771
2017-11-15
ENDPEndo International PlcKimmel Roger HDirS - Sale$6.90-9,134275,079-3%-$63,025
M
2017-11-15
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+27,00024,216,1890%+$1,316
2017-11-16
CRBPCorbus Pharmaceuticals Holdings, Inc.Panayiotopoulos ParisDirP - Purchase$7.03+14,28514,285New+$100,392
2017-11-15
RETAReata Pharmaceuticals IncBass James EdwardDirP - Purchase$24.02+3,888110,112+4%+$93,390
M
2017-11-14
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$7.00-35,0003,801,394-1%-$245,100
M
2017-11-14
ZSANZosano Pharma CorpGreathouse KennethDirP - Purchase$0.62+50,00050,000New+$31,159
2017-11-14
SELBSelecta Biosciences IncSpringer Timothy ADirP - Purchase$9.27+57,5982,148,953+3%+$534,095
M
2017-11-14
MYOSMyos Rens Technology Inc.Mannello JosephCEOP - Purchase$1.31+25,000216,810+13%+$32,766
D
2017-11-14
ABTAbbott LaboratoriesSalvadori Daniel Gesua SiveEVPS - Sale+OE$55.00-71,15773,798-49%-$3,913,635
2017-11-15
XENEXenon Pharmaceuticals Inc.Azab MohammadDirP - Purchase$2.22+15,00044,210+51%+$33,281
2017-11-15
CLVSClovis Oncology, Inc.Ivers-Read Gillian CSee RemarksS - Sale$63.70-3,000185,583-2%-$191,100
2017-11-14
DMPIDelmar Pharmaceuticals, Inc.Zarrabian SaiidInterim CEOP - Purchase$0.82+60,90060,900New+$50,056
2017-11-14
TYMETyme Technologies, Inc.Hoffman SteveChief ExecOfficer, 10%S - Sale$3.34-50,00026,682,4390%-$167,000
2017-11-14
TYMETyme Technologies, Inc.Demurjian MichaelCOO, 10%S - Sale$3.34-50,00026,680,4360%-$167,000
D
2017-11-14
INSMInsmed IncHayden Donald J JrDirS - Sale+OE$32.50-15,00056,131-21%-$487,500
2017-11-14
CLRBCellectar Biosciences, Inc.Neis JohnDirS - Sale$1.49-5,214626,103-1%-$7,791
D
2017-11-16
MRTXMirati Therapeutics, Inc.Venbio Select Advisor LLC10%P - Purchase$13.00+650,0008,758,702+8%+$8,450,000
D
2017-11-14
LPTXLeap Therapeutics, Inc.Onsi Douglas ECFO, GC, Treasurer, Secretary, 10%P - Purchase$6.08+1,057,7693,917,265+37%+$6,436,524
D
2017-11-14
LPTXLeap Therapeutics, Inc.Mirabelli ChristopherCEO, Pres, COB, 10%P - Purchase$6.08+1,057,7696,535,671+19%+$6,436,524
D
2017-11-14
LPTXLeap Therapeutics, Inc.Healthcare Ventures Ix, L.P.10%P - Purchase$6.08+1,057,7693,573,376+42%+$6,436,524
D
2017-11-14
LPTXLeap Therapeutics, Inc.Lawlor AugustineCOO, 10%P - Purchase$6.08+1,057,7696,535,671+19%+$6,436,524
2017-11-14
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$26.25+50,0005,698,799+1%+$1,312,390
2017-11-15
CRBPCorbus Pharmaceuticals Holdings, Inc.Hochman David PDirP - Purchase$6.55+5,000692,400+1%+$32,750
2017-11-15
ATOSAtossa Genetics IncGuse KyleCFO, GC, SecretaryP - Purchase$0.34+10,00010,000New+$3,369
M
2017-11-13
BGNEBeigene, Ltd.Oyler JohnCEO, 10%S - Sale$80.50-150,95763,549,5930%-$12,152,374
2017-11-13
BGNEBeigene, Ltd.Peterson Amy C.CMO, Immuno-oncologyS - Sale$82.96-3,601225,002-2%-$298,747
DM
2017-11-13
XOMAXoma CorpNeal James RCEOS - Sale+OE$28.24-46,29619,294-71%-$1,307,187
DM
2017-11-13
XOMAXoma CorpBurns Thomas M.SVP, Finance, CFOS - Sale+OE$28.69-22,2228,945-71%-$637,450
D
2017-11-13
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerS - Sale+OE$16.97-7,0003,822-65%-$118,761
D
2017-11-13
NKTRNektar TherapeuticsNicholson JohnSVP, COOS - Sale+OE$37.78-15,910233,156-6%-$601,080
D
2017-11-13
ALDRAlder Biopharmaceuticals IncLitton Mark JamesChief Business OfficerS - Sale+OE$10.80-16,519177,932-8%-$178,486
M
2017-11-13
AGIOAgios Pharmaceuticals IncCantley Lewis Clayton Jr.DirS - Sale$60.88-4,000204,434-2%-$243,540
D
2017-11-13
CORTCorcept Therapeutics IncBaker G Leonard JrDirS - Sale+OE$17.59-30,0004,345,527-1%-$527,556
2017-11-15
LXRXLexicon Pharmaceuticals, Inc.Coats LonnelPres, CEOP - Purchase$9.91+10,00042,985+30%+$99,100
D
2017-11-13
GTHXG1 Therapeutics, Inc.Eshelman Fredric NDir, 10%P - Purchase$19.73+250,0003,689,151+7%+$4,932,500
M
2017-11-13
EBSEmergent Biosolutions Inc.El-Hibri FuadCOB, 10%S - Sale$40.37-40,0007,358,621-1%-$1,614,800
M
2017-11-13
WVEWave Life Sciences Ltd.Ra Capital Management, LLCDir, 10%P - Purchase$23.34+423,3987,512,049+6%+$9,881,550
D
2017-11-13
APLSApellis Pharmaceuticals, Inc.Hillhouse Capital Management, Ltd.10%P - Purchase$14.00+1,428,5713,527,152+68%+$19,999,994
M
2017-11-10
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+36,00024,189,1890%+$1,727
2017-11-14
MNKMallinckrodt PlcWatkins Ian JCHROP - Purchase$21.08+2,00028,525+8%+$42,156
2017-11-14
MNKMallinckrodt PlcO'Neill Hugh M.EVP, Pres, ARDP - Purchase$21.80+9,00040,297+29%+$196,200
2017-11-14
ACRXAcelrx Pharmaceuticals IncEdwards Mark GDirP - Purchase$1.90+30,000150,000+25%+$56,970
2017-11-14
SELBSelecta Biosciences IncAbraham DavidGC, CCO, Corporate SecretaryP - Purchase$9.25+5,4055,405New+$49,996
2017-11-13
SELBSelecta Biosciences IncCautreels WernerPres, CEOP - Purchase$9.31+20,000321,203+7%+$186,250
M
2017-11-10
LXRXLexicon Pharmaceuticals, Inc.Invus Public Equities, L.P.Dir, 10%P - Purchase$9.64+575,94658,093,923+1%+$5,554,166
2017-11-14
LXRXLexicon Pharmaceuticals, Inc.Wade Jeffrey LEVP, Corp Adm Affairs, CFOP - Purchase$9.48+2,00050,597+4%+$18,962
2017-11-13
IONSIonis Pharmaceuticals IncKlein Joseph IIIDirS - Sale$55.39-3,0007,227-29%-$166,170
DM
2017-11-10
ADROAduro Biotech, Inc.Isaacs Stephen TPres, CEOS - Sale+OE$7.97-19,800244,578-7%-$157,723
DM
2017-11-10
ADROAduro Biotech, Inc.Brockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.00-5,87773,718-7%-$47,040
DM
2017-11-09
BHVNBiohaven Pharmaceutical Holding Co Ltd.Engelhart JamesCFOS - Sale+OE$26.58-30,5383,576-90%-$811,561
M
2017-11-09
BHVNBiohaven Pharmaceutical Holding Co Ltd.Berman RobertChief Medical OfficerS - Sale$25.76-160,0001,140,050-12%-$4,122,064
2017-11-10
CBAYCymabay Therapeutics, Inc.Emster Kurt VonDirS - Sale$9.26-50,0481,273,659-4%-$463,379
2017-11-10
SGYPSynergy Pharmaceuticals, Inc.Paulson & Co. Inc.10%S - Sale$2.82-8,750,00015,312,368-36%-$24,678,500
D
2017-11-13
APLSApellis Pharmaceuticals, Inc.Cormorant Asset Management, LLC10%P - Purchase$14.00+1,071,4283,473,925+45%+$14,999,992
2017-11-10
IRWDIronwood Pharmaceuticals IncConsylman GinaInterim CFO, CAOS - Sale$15.20-86452,001-2%-$13,133
2017-11-13
ECYTEndocyte IncLow Philip SChief Science OfficerP - Purchase$4.84+5,600481,923+1%+$27,104
2017-11-13
LFVNLifevantage CorpJensen Darren JayCEOP - Purchase$5.06+2,000151,358+1%+$10,130
M
2017-09-11
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.19+203,0004,226,742+5%+$38,275

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top